nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Capecitabine—colon cancer	0.184	0.441	CbGbCtD
Guanfacine—CYP2C9—Fluorouracil—colon cancer	0.109	0.262	CbGbCtD
Guanfacine—CYP3A4—Irinotecan—colon cancer	0.0661	0.158	CbGbCtD
Guanfacine—CYP3A4—Vincristine—colon cancer	0.0577	0.139	CbGbCtD
Guanfacine—NISCH—Vinblastine—Vincristine—colon cancer	0.0256	1	CbGdCrCtD
Guanfacine—Paresis—Vincristine—colon cancer	0.0184	0.0333	CcSEcCtD
Guanfacine—Abdominal pain lower—Capecitabine—colon cancer	0.0138	0.0249	CcSEcCtD
Guanfacine—Hypokinesia—Irinotecan—colon cancer	0.00971	0.0175	CcSEcCtD
Guanfacine—Paresis—Methotrexate—colon cancer	0.00895	0.0162	CcSEcCtD
Guanfacine—Loss of libido—Methotrexate—colon cancer	0.00707	0.0128	CcSEcCtD
Guanfacine—Renal failure acute—Irinotecan—colon cancer	0.00515	0.0093	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00504	0.0091	CcSEcCtD
Guanfacine—Pain in extremity—Vincristine—colon cancer	0.00488	0.00882	CcSEcCtD
Guanfacine—Cerebrovascular accident—Irinotecan—colon cancer	0.00485	0.00876	CcSEcCtD
Guanfacine—Amnesia—Fluorouracil—colon cancer	0.00485	0.00875	CcSEcCtD
Guanfacine—Nocturia—Capecitabine—colon cancer	0.00473	0.00853	CcSEcCtD
Guanfacine—Lethargy—Fluorouracil—colon cancer	0.00465	0.00839	CcSEcCtD
Guanfacine—Irritability—Fluorouracil—colon cancer	0.00435	0.00785	CcSEcCtD
Guanfacine—Orthostatic hypotension—Irinotecan—colon cancer	0.00435	0.00784	CcSEcCtD
Guanfacine—Urinary incontinence—Capecitabine—colon cancer	0.00424	0.00764	CcSEcCtD
Guanfacine—Skin exfoliation—Capecitabine—colon cancer	0.00419	0.00756	CcSEcCtD
Guanfacine—Dysphagia—Fluorouracil—colon cancer	0.00394	0.00711	CcSEcCtD
Guanfacine—Erectile dysfunction—Vincristine—colon cancer	0.00389	0.00702	CcSEcCtD
Guanfacine—Acute coronary syndrome—Vincristine—colon cancer	0.00371	0.0067	CcSEcCtD
Guanfacine—Myocardial infarction—Vincristine—colon cancer	0.00369	0.00666	CcSEcCtD
Guanfacine—Acute coronary syndrome—Irinotecan—colon cancer	0.00361	0.00652	CcSEcCtD
Guanfacine—Sweating—Vincristine—colon cancer	0.00361	0.00651	CcSEcCtD
Guanfacine—Myocardial infarction—Irinotecan—colon cancer	0.00359	0.00649	CcSEcCtD
Guanfacine—Vascular purpura—Capecitabine—colon cancer	0.00356	0.00642	CcSEcCtD
Guanfacine—Sweating—Irinotecan—colon cancer	0.00351	0.00634	CcSEcCtD
Guanfacine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00346	0.00625	CcSEcCtD
Guanfacine—Renal failure acute—Capecitabine—colon cancer	0.00345	0.00622	CcSEcCtD
Guanfacine—Myocardial infarction—Fluorouracil—colon cancer	0.00344	0.00621	CcSEcCtD
Guanfacine—Conjunctivitis—Fluorouracil—colon cancer	0.00341	0.00616	CcSEcCtD
Guanfacine—Amnesia—Capecitabine—colon cancer	0.00339	0.00612	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00337	0.00609	CcSEcCtD
Guanfacine—Hallucination—Vincristine—colon cancer	0.00336	0.00607	CcSEcCtD
Guanfacine—Bradycardia—Irinotecan—colon cancer	0.00335	0.00605	CcSEcCtD
Guanfacine—Purpura—Capecitabine—colon cancer	0.0033	0.00596	CcSEcCtD
Guanfacine—Rhinitis—Irinotecan—colon cancer	0.0033	0.00595	CcSEcCtD
Guanfacine—Lethargy—Capecitabine—colon cancer	0.00325	0.00586	CcSEcCtD
Guanfacine—Cerebrovascular accident—Capecitabine—colon cancer	0.00325	0.00586	CcSEcCtD
Guanfacine—Pain in extremity—Capecitabine—colon cancer	0.00318	0.00575	CcSEcCtD
Guanfacine—Visual impairment—Irinotecan—colon cancer	0.00317	0.00572	CcSEcCtD
Guanfacine—Rhinitis—Fluorouracil—colon cancer	0.00316	0.0057	CcSEcCtD
Guanfacine—Skin exfoliation—Methotrexate—colon cancer	0.00312	0.00563	CcSEcCtD
Guanfacine—Irritability—Capecitabine—colon cancer	0.00304	0.00548	CcSEcCtD
Guanfacine—Alopecia—Vincristine—colon cancer	0.00299	0.00539	CcSEcCtD
Guanfacine—Immune system disorder—Irinotecan—colon cancer	0.00297	0.00536	CcSEcCtD
Guanfacine—Liver function test abnormal—Capecitabine—colon cancer	0.00294	0.00531	CcSEcCtD
Guanfacine—Alopecia—Irinotecan—colon cancer	0.00291	0.00525	CcSEcCtD
Guanfacine—Orthostatic hypotension—Capecitabine—colon cancer	0.00291	0.00525	CcSEcCtD
Guanfacine—Abdominal pain upper—Capecitabine—colon cancer	0.00291	0.00525	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00281	0.00507	CcSEcCtD
Guanfacine—Alopecia—Fluorouracil—colon cancer	0.00279	0.00503	CcSEcCtD
Guanfacine—Muscle spasms—Irinotecan—colon cancer	0.00275	0.00497	CcSEcCtD
Guanfacine—Dysphagia—Capecitabine—colon cancer	0.00275	0.00497	CcSEcCtD
Guanfacine—Asthma—Capecitabine—colon cancer	0.00275	0.00497	CcSEcCtD
Guanfacine—Agitation—Vincristine—colon cancer	0.0027	0.00488	CcSEcCtD
Guanfacine—Ill-defined disorder—Irinotecan—colon cancer	0.00266	0.0048	CcSEcCtD
Guanfacine—Vertigo—Vincristine—colon cancer	0.00264	0.00477	CcSEcCtD
Guanfacine—Abdominal discomfort—Capecitabine—colon cancer	0.00264	0.00476	CcSEcCtD
Guanfacine—Vision blurred—Fluorouracil—colon cancer	0.00259	0.00467	CcSEcCtD
Guanfacine—Malaise—Irinotecan—colon cancer	0.00258	0.00466	CcSEcCtD
Guanfacine—Vertigo—Irinotecan—colon cancer	0.00257	0.00465	CcSEcCtD
Guanfacine—Syncope—Irinotecan—colon cancer	0.00257	0.00464	CcSEcCtD
Guanfacine—Renal failure acute—Methotrexate—colon cancer	0.00257	0.00463	CcSEcCtD
Guanfacine—Convulsion—Vincristine—colon cancer	0.00255	0.0046	CcSEcCtD
Guanfacine—Hypertension—Vincristine—colon cancer	0.00254	0.00458	CcSEcCtD
Guanfacine—Loss of consciousness—Irinotecan—colon cancer	0.00252	0.00454	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00251	0.00453	CcSEcCtD
Guanfacine—Myalgia—Vincristine—colon cancer	0.0025	0.00452	CcSEcCtD
Guanfacine—Weight increased—Capecitabine—colon cancer	0.0025	0.00452	CcSEcCtD
Guanfacine—Hypertension—Irinotecan—colon cancer	0.00247	0.00446	CcSEcCtD
Guanfacine—Acute coronary syndrome—Capecitabine—colon cancer	0.00242	0.00437	CcSEcCtD
Guanfacine—Lethargy—Methotrexate—colon cancer	0.00242	0.00437	CcSEcCtD
Guanfacine—Cerebrovascular accident—Methotrexate—colon cancer	0.00242	0.00437	CcSEcCtD
Guanfacine—Discomfort—Irinotecan—colon cancer	0.00241	0.00435	CcSEcCtD
Guanfacine—Myocardial infarction—Capecitabine—colon cancer	0.00241	0.00434	CcSEcCtD
Guanfacine—Oedema—Vincristine—colon cancer	0.0024	0.00433	CcSEcCtD
Guanfacine—Conjunctivitis—Capecitabine—colon cancer	0.00239	0.0043	CcSEcCtD
Guanfacine—Convulsion—Fluorouracil—colon cancer	0.00238	0.00429	CcSEcCtD
Guanfacine—Confusional state—Irinotecan—colon cancer	0.00236	0.00425	CcSEcCtD
Guanfacine—Oedema—Irinotecan—colon cancer	0.00234	0.00422	CcSEcCtD
Guanfacine—Myalgia—Fluorouracil—colon cancer	0.00234	0.00422	CcSEcCtD
Guanfacine—Chest pain—Fluorouracil—colon cancer	0.00234	0.00422	CcSEcCtD
Guanfacine—Hyperhidrosis—Vincristine—colon cancer	0.00232	0.00419	CcSEcCtD
Guanfacine—Discomfort—Fluorouracil—colon cancer	0.00231	0.00417	CcSEcCtD
Guanfacine—Shock—Irinotecan—colon cancer	0.0023	0.00415	CcSEcCtD
Guanfacine—Irritability—Methotrexate—colon cancer	0.00226	0.00408	CcSEcCtD
Guanfacine—Hyperhidrosis—Irinotecan—colon cancer	0.00226	0.00408	CcSEcCtD
Guanfacine—Confusional state—Fluorouracil—colon cancer	0.00226	0.00408	CcSEcCtD
Guanfacine—Hypotension—Vincristine—colon cancer	0.00224	0.00405	CcSEcCtD
Guanfacine—Bradycardia—Capecitabine—colon cancer	0.00224	0.00405	CcSEcCtD
Guanfacine—Oedema—Fluorouracil—colon cancer	0.00224	0.00404	CcSEcCtD
Guanfacine—Rhinitis—Capecitabine—colon cancer	0.00221	0.00399	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—colon cancer	0.00219	0.00395	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00219	0.00395	CcSEcCtD
Guanfacine—Tachycardia—Fluorouracil—colon cancer	0.00219	0.00394	CcSEcCtD
Guanfacine—Hypotension—Irinotecan—colon cancer	0.00218	0.00394	CcSEcCtD
Guanfacine—Insomnia—Vincristine—colon cancer	0.00217	0.00392	CcSEcCtD
Guanfacine—Paraesthesia—Vincristine—colon cancer	0.00216	0.00389	CcSEcCtD
Guanfacine—Visual impairment—Capecitabine—colon cancer	0.00212	0.00383	CcSEcCtD
Guanfacine—Insomnia—Irinotecan—colon cancer	0.00211	0.00382	CcSEcCtD
Guanfacine—Paraesthesia—Irinotecan—colon cancer	0.0021	0.00379	CcSEcCtD
Guanfacine—Hypotension—Fluorouracil—colon cancer	0.00209	0.00378	CcSEcCtD
Guanfacine—Decreased appetite—Vincristine—colon cancer	0.00209	0.00377	CcSEcCtD
Guanfacine—Dyspnoea—Irinotecan—colon cancer	0.00208	0.00376	CcSEcCtD
Guanfacine—Somnolence—Irinotecan—colon cancer	0.00208	0.00375	CcSEcCtD
Guanfacine—Fatigue—Vincristine—colon cancer	0.00207	0.00374	CcSEcCtD
Guanfacine—Eye disorder—Capecitabine—colon cancer	0.00206	0.00371	CcSEcCtD
Guanfacine—Dyspepsia—Irinotecan—colon cancer	0.00206	0.00371	CcSEcCtD
Guanfacine—Tinnitus—Capecitabine—colon cancer	0.00205	0.00371	CcSEcCtD
Guanfacine—Constipation—Vincristine—colon cancer	0.00205	0.00371	CcSEcCtD
Guanfacine—Asthma—Methotrexate—colon cancer	0.00205	0.0037	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00204	0.00368	CcSEcCtD
Guanfacine—Decreased appetite—Irinotecan—colon cancer	0.00203	0.00367	CcSEcCtD
Guanfacine—Insomnia—Fluorouracil—colon cancer	0.00203	0.00366	CcSEcCtD
Guanfacine—Fatigue—Irinotecan—colon cancer	0.00202	0.00364	CcSEcCtD
Guanfacine—Paraesthesia—Fluorouracil—colon cancer	0.00201	0.00363	CcSEcCtD
Guanfacine—Constipation—Irinotecan—colon cancer	0.002	0.00361	CcSEcCtD
Guanfacine—Dyspnoea—Fluorouracil—colon cancer	0.002	0.0036	CcSEcCtD
Guanfacine—Somnolence—Fluorouracil—colon cancer	0.00199	0.00359	CcSEcCtD
Guanfacine—Immune system disorder—Capecitabine—colon cancer	0.00199	0.00359	CcSEcCtD
Guanfacine—Dyspepsia—Fluorouracil—colon cancer	0.00197	0.00356	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—colon cancer	0.00196	0.00354	CcSEcCtD
Guanfacine—Gastrointestinal pain—Vincristine—colon cancer	0.00196	0.00354	CcSEcCtD
Guanfacine—Decreased appetite—Fluorouracil—colon cancer	0.00195	0.00351	CcSEcCtD
Guanfacine—Alopecia—Capecitabine—colon cancer	0.00195	0.00351	CcSEcCtD
Guanfacine—Feeling abnormal—Irinotecan—colon cancer	0.00193	0.00348	CcSEcCtD
Guanfacine—Gastrointestinal pain—Irinotecan—colon cancer	0.00191	0.00345	CcSEcCtD
Guanfacine—Abdominal pain—Vincristine—colon cancer	0.0019	0.00343	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—colon cancer	0.00189	0.00341	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—colon cancer	0.00188	0.541	CrCbGaD
Guanfacine—Dysgeusia—Capecitabine—colon cancer	0.00188	0.00339	CcSEcCtD
Guanfacine—Abdominal pain—Irinotecan—colon cancer	0.00185	0.00334	CcSEcCtD
Guanfacine—Feeling abnormal—Fluorouracil—colon cancer	0.00185	0.00333	CcSEcCtD
Guanfacine—Muscle spasms—Capecitabine—colon cancer	0.00184	0.00333	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—colon cancer	0.00183	0.0033	CcSEcCtD
Guanfacine—Vision blurred—Capecitabine—colon cancer	0.00181	0.00326	CcSEcCtD
Guanfacine—Tremor—Capecitabine—colon cancer	0.0018	0.00324	CcSEcCtD
Guanfacine—Ill-defined disorder—Capecitabine—colon cancer	0.00178	0.00321	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—colon cancer	0.00178	0.0032	CcSEcCtD
Guanfacine—Hypersensitivity—Vincristine—colon cancer	0.00177	0.00319	CcSEcCtD
Guanfacine—Sweating—Methotrexate—colon cancer	0.00175	0.00316	CcSEcCtD
Guanfacine—Malaise—Capecitabine—colon cancer	0.00173	0.00312	CcSEcCtD
Guanfacine—Vertigo—Capecitabine—colon cancer	0.00172	0.00311	CcSEcCtD
Guanfacine—Hypersensitivity—Irinotecan—colon cancer	0.00172	0.00311	CcSEcCtD
Guanfacine—Asthenia—Vincristine—colon cancer	0.00172	0.00311	CcSEcCtD
Guanfacine—Syncope—Capecitabine—colon cancer	0.00172	0.0031	CcSEcCtD
Guanfacine—Palpitations—Capecitabine—colon cancer	0.00169	0.00306	CcSEcCtD
Guanfacine—Loss of consciousness—Capecitabine—colon cancer	0.00169	0.00304	CcSEcCtD
Guanfacine—Asthenia—Irinotecan—colon cancer	0.00168	0.00303	CcSEcCtD
Guanfacine—Hypertension—Capecitabine—colon cancer	0.00166	0.00299	CcSEcCtD
Guanfacine—Hypersensitivity—Fluorouracil—colon cancer	0.00165	0.00298	CcSEcCtD
Guanfacine—Diarrhoea—Vincristine—colon cancer	0.00164	0.00296	CcSEcCtD
Guanfacine—Myalgia—Capecitabine—colon cancer	0.00163	0.00295	CcSEcCtD
Guanfacine—Arthralgia—Capecitabine—colon cancer	0.00163	0.00295	CcSEcCtD
Guanfacine—Chest pain—Capecitabine—colon cancer	0.00163	0.00295	CcSEcCtD
Guanfacine—Anxiety—Capecitabine—colon cancer	0.00163	0.00294	CcSEcCtD
Guanfacine—Discomfort—Capecitabine—colon cancer	0.00161	0.00291	CcSEcCtD
Guanfacine—Diclofenac—ABCB1—colon cancer	0.0016	0.46	CrCbGaD
Guanfacine—Diarrhoea—Irinotecan—colon cancer	0.0016	0.00289	CcSEcCtD
Guanfacine—Dry mouth—Capecitabine—colon cancer	0.0016	0.00288	CcSEcCtD
Guanfacine—Dizziness—Vincristine—colon cancer	0.00159	0.00287	CcSEcCtD
Guanfacine—Pruritus—Fluorouracil—colon cancer	0.00158	0.00286	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—colon cancer	0.00158	0.00285	CcSEcCtD
Guanfacine—Confusional state—Capecitabine—colon cancer	0.00158	0.00285	CcSEcCtD
Guanfacine—Oedema—Capecitabine—colon cancer	0.00156	0.00282	CcSEcCtD
Guanfacine—Dizziness—Irinotecan—colon cancer	0.00155	0.00279	CcSEcCtD
Guanfacine—Shock—Capecitabine—colon cancer	0.00154	0.00278	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—colon cancer	0.00153	0.00277	CcSEcCtD
Guanfacine—Diarrhoea—Fluorouracil—colon cancer	0.00153	0.00277	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—colon cancer	0.00153	0.00276	CcSEcCtD
Guanfacine—Tachycardia—Capecitabine—colon cancer	0.00153	0.00276	CcSEcCtD
Guanfacine—Vomiting—Vincristine—colon cancer	0.00153	0.00275	CcSEcCtD
Guanfacine—Rash—Vincristine—colon cancer	0.00151	0.00273	CcSEcCtD
Guanfacine—Hyperhidrosis—Capecitabine—colon cancer	0.00151	0.00273	CcSEcCtD
Guanfacine—Dermatitis—Vincristine—colon cancer	0.00151	0.00273	CcSEcCtD
Guanfacine—Headache—Vincristine—colon cancer	0.0015	0.00271	CcSEcCtD
Guanfacine—Vomiting—Irinotecan—colon cancer	0.00149	0.00268	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—colon cancer	0.00148	0.00267	CcSEcCtD
Guanfacine—Dizziness—Fluorouracil—colon cancer	0.00148	0.00267	CcSEcCtD
Guanfacine—Rash—Irinotecan—colon cancer	0.00147	0.00266	CcSEcCtD
Guanfacine—Dermatitis—Irinotecan—colon cancer	0.00147	0.00266	CcSEcCtD
Guanfacine—Headache—Irinotecan—colon cancer	0.00146	0.00264	CcSEcCtD
Guanfacine—Hypotension—Capecitabine—colon cancer	0.00146	0.00264	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—colon cancer	0.00145	0.00262	CcSEcCtD
Guanfacine—Nausea—Vincristine—colon cancer	0.00143	0.00257	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00143	0.00257	CcSEcCtD
Guanfacine—Vomiting—Fluorouracil—colon cancer	0.00142	0.00257	CcSEcCtD
Guanfacine—Insomnia—Capecitabine—colon cancer	0.00142	0.00255	CcSEcCtD
Guanfacine—Rash—Fluorouracil—colon cancer	0.00141	0.00255	CcSEcCtD
Guanfacine—Dermatitis—Fluorouracil—colon cancer	0.00141	0.00255	CcSEcCtD
Guanfacine—Paraesthesia—Capecitabine—colon cancer	0.00141	0.00254	CcSEcCtD
Guanfacine—Headache—Fluorouracil—colon cancer	0.0014	0.00253	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—colon cancer	0.0014	0.00252	CcSEcCtD
Guanfacine—Dyspnoea—Capecitabine—colon cancer	0.0014	0.00252	CcSEcCtD
Guanfacine—Nausea—Irinotecan—colon cancer	0.00139	0.00251	CcSEcCtD
Guanfacine—Dyspepsia—Capecitabine—colon cancer	0.00138	0.00249	CcSEcCtD
Guanfacine—Decreased appetite—Capecitabine—colon cancer	0.00136	0.00246	CcSEcCtD
Guanfacine—Fatigue—Capecitabine—colon cancer	0.00135	0.00243	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—colon cancer	0.00135	0.00243	CcSEcCtD
Guanfacine—Constipation—Capecitabine—colon cancer	0.00134	0.00242	CcSEcCtD
Guanfacine—Nausea—Fluorouracil—colon cancer	0.00133	0.0024	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—colon cancer	0.00132	0.00239	CcSEcCtD
Guanfacine—Feeling abnormal—Capecitabine—colon cancer	0.00129	0.00233	CcSEcCtD
Guanfacine—Malaise—Methotrexate—colon cancer	0.00129	0.00232	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—colon cancer	0.00128	0.00231	CcSEcCtD
Guanfacine—Gastrointestinal pain—Capecitabine—colon cancer	0.00128	0.00231	CcSEcCtD
Guanfacine—Abdominal pain—Capecitabine—colon cancer	0.00124	0.00223	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—colon cancer	0.00124	0.00223	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—colon cancer	0.00122	0.00219	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—colon cancer	0.00122	0.00219	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—colon cancer	0.00122	0.00219	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—colon cancer	0.0012	0.00217	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—colon cancer	0.00117	0.00212	CcSEcCtD
Guanfacine—Hypersensitivity—Capecitabine—colon cancer	0.00115	0.00208	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—colon cancer	0.00113	0.00203	CcSEcCtD
Guanfacine—Asthenia—Capecitabine—colon cancer	0.00112	0.00203	CcSEcCtD
Guanfacine—Pruritus—Capecitabine—colon cancer	0.00111	0.002	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—colon cancer	0.00109	0.00196	CcSEcCtD
Guanfacine—Diarrhoea—Capecitabine—colon cancer	0.00107	0.00193	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00106	0.00192	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—colon cancer	0.00105	0.0019	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—colon cancer	0.00105	0.00189	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—colon cancer	0.00104	0.00187	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—colon cancer	0.00104	0.00187	CcSEcCtD
Guanfacine—Dizziness—Capecitabine—colon cancer	0.00103	0.00187	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—colon cancer	0.00103	0.00185	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—colon cancer	0.00101	0.00183	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—colon cancer	0.001	0.00181	CcSEcCtD
Guanfacine—Vomiting—Capecitabine—colon cancer	0.000995	0.0018	CcSEcCtD
Guanfacine—Rash—Capecitabine—colon cancer	0.000987	0.00178	CcSEcCtD
Guanfacine—Dermatitis—Capecitabine—colon cancer	0.000986	0.00178	CcSEcCtD
Guanfacine—Headache—Capecitabine—colon cancer	0.00098	0.00177	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—colon cancer	0.00096	0.00173	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—colon cancer	0.000953	0.00172	CcSEcCtD
Guanfacine—Nausea—Capecitabine—colon cancer	0.00093	0.00168	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—colon cancer	0.000921	0.00166	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—colon cancer	0.000858	0.00155	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—colon cancer	0.000836	0.00151	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—colon cancer	0.000824	0.00149	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—colon cancer	0.000797	0.00144	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—colon cancer	0.00077	0.00139	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—colon cancer	0.000741	0.00134	CcSEcCtD
Guanfacine—Rash—Methotrexate—colon cancer	0.000735	0.00133	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—colon cancer	0.000734	0.00132	CcSEcCtD
Guanfacine—Headache—Methotrexate—colon cancer	0.00073	0.00132	CcSEcCtD
Guanfacine—Nausea—Methotrexate—colon cancer	0.000692	0.00125	CcSEcCtD
